+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Osteoporosis Drugs Companies in China

  • PDF Icon

    Report

  • 67 Pages
  • November 2023
  • Region: China
  • AMID Co
  • ID: 3453717

China's demand for Osteoporosis Drugs will continue to grow at 9% by 2032

This study focuses on China’s Osteoporosis Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market.

Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation and investment in R&D and new product development. The sector’s economies of scale have yet to be achieved. Most domestic manufacturers lack the autonomic intellectual property and financial resources to develop their own brand name products.

This new study analyzes the industry structure, capacities and output. Major producers' production locations, market shares and profiles are presented. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and the in-house databases.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
III. OSTEOPOROSIS DRUGS INDUSTRY ASSESSMENTS
  • Osteoporosis Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Major Osteoporosis Drugs Manufacturers
  • Labor Cost
  • Potential Entrants
  • Major Foreign Investments
VII. OSTEOPOROSIS DRUGS PRODUCER DIRECTORY
  • Osteoporosis Drugs Producer Profiles
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
III. OSTEOPOROSIS DRUGS INDUSTRY ASSESSMENTS
  • China's Major Class of Osteoporosis Drugs
  • China's Osteoporosis Drugs Sales Volume and Market Share by Class
  • China’s Major Calcium Drugs Manufacturers and Locations
  • China’s Major Bisphosphonate Drugs Manufacturers and Locations
  • China’s Major Calcitonin Drugs Manufacturers and Locations
  • China’s Major Estrogen Drugs Manufacturers and Locations
  • Major Foreign Investments in China
LIST OF CHARTS
I. INTRODUCTION
  • China’s Osteoporosis Drugs Sales Volume
  • China’s Major Class of Osteoporosis Drugs
II. OSTEOPOROSIS DRUGS INDUSTRY ASSESSMENTS
  • China's Osteoporosis Drugs Sales Volume and Market Share by Class
  • China’s Osteoporosis Drugs Sales Volume
  • China’s Major Calcium Drugs Manufacturers Location by Province
  • China’s Major Bisphosphonate Drugs Manufacturers Location by Province
  • China’s Major Calcitonin Drugs Manufacturers Location by Province
  • China’s Major Estrogen Drugs Manufacturers Location by Province

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Hubei Niulan Pharmaceutical Co., Ltd
  • Shanghai Baolong Pharmaceutical Co., Ltd